Chemoinformaics analysis of 1,3,4-TRI-O-GALLOYLQUINIC-ACID
Molecular Weight | 648.482 | nRot | 7 |
Heavy Atom Molecular Weight | 624.29 | nRig | 28 |
Exact Molecular Weight | 648.096 | nRing | 4 |
Solubility: LogS | -2.428 | nHRing | 0 |
Solubility: LogP | 1.066 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 70 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 46 | No. of Aromatic Carbocycles | 3 |
nHetero | 18 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 28 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
No. of Oxygen atom | 18 | No. of Arom Bond | 18 |
nHA | 17 | APOL | 77.199 |
nHD | 11 | BPOL | 32.757 |
QED | 0.095 |
Synth | 4.43 |
Natural Product Likeliness | 1.286 |
NR-PPAR-gamma | 0.386 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.989 |
CACO-2 | -6.81 |
MDCK | 0.0000119 |
BBB | 0.012 |
PPB | 0.844735 |
VDSS | 0.473 |
FU | 0.181298 |
CYP1A2-inh | 0.227 |
CYP1A2-sub | 0.018 |
CYP2c19-inh | 0.009 |
CYP2c19-sub | 0.022 |
CYP2c9-inh | 0.327 |
CYP2c9-sub | 0.031 |
CYP2d6-inh | 0.001 |
CYP2d6-sub | 0.078 |
CYP3a4-inh | 0.034 |
CYP3a4-sub | 0.006 |
CL | 9.36 |
T12 | 0.982 |
hERG | 0.024 |
Ames | 0.016 |
ROA | 0 |
SkinSen | 0.933 |
Carcinogencity | 0.002 |
EI | 0.897 |
Respiratory | 0.003 |
NR-Aromatase | 0.239 |
Antiviral | Yes |
Prediction | 0.778273 |